Study guide

24.10 Re-Evaluation, Endpoints and Periodontal Surgery

Overseas Registration Examination ORE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: ORE Part 1 — Exam Blueprint, Logistics and Strategy

1.1 Structure and Format of ORE Part 1 1.2 The Official Blueprint and Preparing for Practice 1.3 Eligibility, Fees, Attempts and Time Limits

2 Chapter 2: Anatomy of the Head and Neck

2.1 The Trigeminal Nerve and Dental Innervation 2.2 The Facial Nerve and Parotid Region 2.3 The Temporomandibular Joint and Muscles of Mastication 2.4 The Infratemporal Fossa and Spread of Odontogenic Infection

3 Chapter 3: Dental Anatomy, Morphology and Occlusion

3.1 Permanent and Primary Tooth Morphology 3.2 Functional Occlusion: Centric Relation, Guidance and Interferences 3.3 Classifying Occlusion: Angle and BSI Incisor Relationships

4 Chapter 4: Genetics, Embryology and Odontogenesis

4.1 Stages of Odontogenesis and Molecular Signalling 4.2 Amelogenesis and Enamel Microstructure 4.3 Dentinogenesis and the Pulp-Dentine Complex 4.4 Cementum, the Periodontal Ligament and Oral Mucosa 4.5 Genetic and Developmental Dental Anomalies

5 Chapter 5: Oral Biology and Salivary Physiology

5.1 Salivary Gland Anatomy, Microarchitecture and Innervation 5.2 Salivary Secretion, Flow Rates and Autonomic Control 5.3 Salivary Buffering Systems and Protective Macromolecules 5.4 Physiology of Mastication and Deglutition 5.5 Taste, Lingual Papillae and Gustatory Pathways 5.6 Xerostomia, Sjogren's Syndrome and Salivary Diagnostics

6 Chapter 6: Physiology of the Major Body Systems

6.1 Cardiovascular and Respiratory Physiology 6.2 Renal, Endocrine and Gastrointestinal Physiology 6.3 Haematology and Haemostasis 6.4 Neurophysiology, Pain and the Autonomic Nervous System

7 Chapter 7: Bone Biology, Calcium Homeostasis and Healing

7.1 Microstructure and Architecture of Alveolar Bone 7.2 Bone Remodelling and the RANK/RANKL/OPG Axis 7.3 Endocrine Control of Calcium and Phosphate 7.4 Extraction Socket Healing and Ridge Resorption 7.5 Impaired Healing: MRONJ, Osteoradionecrosis and Systemic Risk

8 Chapter 8: Oral Microbiology and Biofilm Ecology

8.1 The Oral Microbiome and Biofilm Development 8.2 Cariogenic Microbiology: Mutans Streptococci and Lactobacilli 8.3 Ecological Hypotheses of Dental Caries 8.4 Biofilm Tolerance and the Case for Mechanical Plaque Control

9 Chapter 9: Immunology Relevant to Oral Disease

9.1 Innate Mucosal Immunity and Gingival Crevicular Fluid 9.2 Cellular Immunity in the Periodontium 9.3 Microbial Pathogenesis: Complexes and Keystone Pathogens 9.4 Host-Mediated Tissue Destruction 9.5 Hypersensitivity Reactions in Dental Practice 9.6 Autoimmune Mucocutaneous Bullous Disease 9.7 Immunodeficiency and Oral HIV Manifestations

10 Chapter 10: General Pathology and Neoplasia

10.1 Cellular Adaptation and Mechanisms of Cell Death 10.2 Inflammation, Wound Healing and Repair 10.3 Principles of Neoplasia and Carcinogenesis 10.4 TNM Staging of Oral Cavity Carcinoma

11 Chapter 11: Statistics and Research Methods

11.1 Study Designs and the Hierarchy of Evidence 11.2 Descriptive and Inferential Statistics 11.3 Diagnostic Test Performance 11.4 Critical Appraisal, Bias and Research Governance

12 Chapter 12: Human Disease: Cardiovascular and Respiratory

12.1 Infective Endocarditis and NICE CG64 12.2 Hypertension and Blood Pressure Thresholds for Dental Care 12.3 Angina, Myocardial Infarction and Antiplatelet Therapy 12.4 Asthma, COPD and Respiratory Emergencies

13 Chapter 13: Human Disease: Endocrine, Haematological and Renal

13.1 Diabetes Mellitus and the Periodontal Axis 13.2 Congenital Bleeding and Clotting Disorders 13.3 Anticoagulants and Antiplatelets: The SDCEP Protocol 13.4 Chronic Kidney Disease and Haemodialysis

14 Chapter 14: Human Disease: Gastrointestinal, Hepatic and Neurological

14.1 Gastrointestinal Disease and Intrinsic Dental Erosion 14.2 Liver Disease, Coagulopathy and Viral Hepatitis 14.3 Epilepsy, Stroke and Transient Ischaemic Attack 14.4 Trigeminal Neuralgia, Bell's Palsy and Giant Cell Arteritis

15 Chapter 15: Oral Aspects of Human Disease

15.1 Oral Manifestations of Systemic Disease 15.2 Orofacial Pain and Temporomandibular Disorders 15.3 Dry Mouth, Altered Taste and Halitosis

16 Chapter 16: Infection Prevention and Control

16.1 The Decontamination Cycle, Sterilization and Waterlines 16.2 Routes of Transmission and Blood-Borne Viruses

17 Chapter 17: Dental Materials

17.1 Dental Amalgam: Metallurgy and UK Regulation 17.2 Resin Composites: Chemistry and Placement 17.3 Dental Adhesive Systems 17.4 Acid Etching, the Hybrid Layer and MMP Degradation 17.5 Glass Ionomer Cements, RMGICs and Compomers 17.6 Impression Materials and Digital Scanning 17.7 Luting Cements and Adhesive Conditioning Protocols 17.8 Dental Ceramics and Cast Alloys 17.9 Gypsum Products, Waxes and Denture Base Polymers

18 Chapter 18: Behavioural Sciences Relevant to Oral Health Care

18.1 Health Behaviour Models and Behaviour Change 18.2 Dental Anxiety and Phobia 18.3 Psychosocial and Sociological Determinants of Oral Health

19 Chapter 19: Patient Assessment and Diagnosis

19.1 History Taking and Clinical Examination 19.2 Special Investigations and Reaching a Diagnosis

20 Chapter 20: Treatment Planning and Risk-Based Care

20.1 Treatment Planning and Sequencing 20.2 Risk Assessment, Recall Intervals and Preventive Planning

21 Chapter 21: Cariology and Caries Risk Assessment

21.1 Caries Pathogenesis and the Stephan Curve 21.2 Histopathology of Enamel and Dentinal Caries 21.3 Caries Diagnosis, ICDAS and Risk Assessment

22 Chapter 22: Operative Dentistry and Minimal Intervention

22.1 Minimal Intervention and Selective Caries Removal 22.2 Pulp Vitality Assessment and Biological Pulp Capping 22.3 Cavity Design, the C-Factor and Margin Geometry

23 Chapter 23: Endodontics

23.1 Pulp Histology and the Low-Compliance Environment 23.2 Pulpal Neurophysiology and Dentine Hypersensitivity 23.3 Pulpal and Periapical Diagnostic Terminology 23.4 Endodontic Diagnostic Testing 23.5 Access Cavity Design and Canal Configurations 23.6 Working Length Determination and Canal Preparation 23.7 Chemical Disinfection and Irrigant Activation 23.8 Medicaments, Obturation Materials and Techniques 23.9 Restoring Endodontically Treated Teeth 23.10 Endodontic Emergencies, Cracked Teeth and Root Fracture

24 Chapter 24: Periodontology

24.1 The 2018 Classification and Periodontal Health 24.2 Plaque-Induced and Non-Plaque-Induced Gingival Disease 24.3 Staging and Grading Periodontitis 24.4 Peri-Implant Disease and Systemic Risk Factors 24.5 The Basic Periodontal Examination 24.6 Simplified BPE in Children and Full Periodontal Charting 24.7 Furcation Involvement, Mobility and Occlusal Trauma 24.8 The BSP Stepwise Treatment Framework 24.9 Periodontal Instrumentation and Healing 24.10 Re-Evaluation, Endpoints and Periodontal Surgery 24.11 Crown Lengthening, Supracrestal Attachment and Supportive Care

25 Chapter 25: Fixed Prosthodontics

25.1 Biomechanical Principles of Tooth Preparation 25.2 Margin Design and the Supracrestal Attachment 25.3 Bridge Design and Resin-Bonded Bridges 25.4 Gingival Retraction, Provisionals and Temporary Cements

26 Chapter 26: Removable Prosthodontics

26.1 Removable Partial Dentures: Classification, Design and Surveying 26.2 Complete Dentures: Principles, Impressions and Jaw Registration

27 Chapter 27: Paediatric Dentistry

27.1 Primary Tooth Anatomy and Caries Management Strategies 27.2 Preformed Metal Crowns and the Hall Technique 27.3 Pulp Therapy in Primary Teeth 27.4 Extractions in the Primary Dentition 27.5 Non-Pharmacological Behaviour Management 27.6 Inhalation Sedation in Paediatric Dentistry 27.7 The Developing Dentition and Space Management 27.8 Serial Extraction and Non-Nutritive Sucking Habits

28 Chapter 28: Dental Traumatology

28.1 Trauma Assessment and Fractures of Permanent Teeth 28.2 Luxation Injuries, Avulsion and Replantation 28.3 Primary Tooth Trauma and Splinting Specifications

29 Chapter 29: Orthodontics

29.1 Extraoral Orthodontic Assessment 29.2 Intraoral Occlusal Assessment 29.3 Skeletal Pattern and Cephalometric Analysis 29.4 IOTN and NHS Treatment Eligibility 29.5 Upper Removable Appliances 29.6 Functional and Fixed Appliances 29.7 Biology of Orthodontic Tooth Movement 29.8 Orthodontic Risks and Retention

30 Chapter 30: Oral Surgery

30.1 Exodontia Biomechanics and Instrument Selection 30.2 Surgical Flap Design, Bone Removal and Suturing 30.3 Third Molar Surgery and NICE Guidance 30.4 Dry Socket and Oroantral Communication 30.5 Odontogenic Infection and Fascial Space Spread

31 Chapter 31: Oral Medicine

31.1 Recurrent Aphthous Stomatitis 31.2 Oral Candidiasis 31.3 Viral Oral Infections 31.4 Reactive Soft Tissue Lesions and the Epulides 31.5 Oral Potentially Malignant Disorders 31.6 Oral Squamous Cell Carcinoma, Urgent Referral and Biopsy

32 Chapter 32: Oral Pathology

32.1 Odontogenic and Non-Odontogenic Cysts 32.2 Odontogenic Tumours 32.3 Obstructive and Reactive Salivary Gland Disease 32.4 Salivary Gland Neoplasms

33 Chapter 33: Therapeutics and Prescribing

33.1 Local Anaesthetic Chemistry and Mechanism of Action 33.2 UK Local Anaesthetic Formulations 33.3 Vasoconstrictors, Maximum Doses and Systemic Toxicity 33.4 Analgesics for Acute Dental Pain 33.5 Antimicrobial Stewardship and First-Line Regimens 33.6 Antifungal and Antiviral Therapeutics

34 Chapter 34: Medical Emergencies in Dental Practice

34.1 The ABCDE Approach and the Emergency Drug Kit 34.2 Anaphylaxis and Acute Coronary Syndrome 34.3 Hypoglycaemia, Acute Asthma and Seizures 34.4 Syncope, Adrenal Crisis, Choking and Resuscitation

35 Chapter 35: Dental Radiology and Radiation Protection

35.1 Radiation Physics, Filtration and Collimation 35.2 Intraoral, Bitewing and Occlusal Projections 35.3 Dental Panoramic Tomography: Principles, Positioning and Errors 35.4 Lateral Cephalometry and Cone Beam CT 35.5 Systematic Reporting and Radiographic Caries Diagnosis 35.6 Radiology of Periodontal Bone Loss and Jaw Lesions 35.7 Radiographic Quality Assurance 35.8 IRR17 and IR(ME)R 2017

36 Chapter 36: Special Care Dentistry and Conscious Sedation

36.1 Special Care Dentistry, Risk Stratification and Sedation Principles 36.2 Inhalation Sedation with Nitrous Oxide 36.3 Intravenous Sedation with Midazolam 36.4 Oral Sedation and General Anaesthesia Referral

37 Chapter 37: Dental Public Health

37.1 Delivering Better Oral Health and the Fluoride Toolkit 37.2 Oral Health Epidemiology and Indices 37.3 Inequalities, Water Fluoridation and Population Prevention 37.4 NHS Dental Services, Access and Commissioning

38 Chapter 38: Communication and Interpersonal Skills

38.1 Patient Communication and Shared Decision-Making 38.2 Breaking Bad News, Complaints and the Duty of Candour 38.3 Referrals, Records and Communication with the Team

39 Chapter 39: Consent and Capacity

39.1 Valid Consent and the Montgomery Standard 39.2 The Mental Capacity Act 2005 39.3 Best Interests Decisions and Lasting Power of Attorney 39.4 Consent in Children and Young People 39.5 Safeguarding Children and Vulnerable Adults 39.6 Confidentiality, Data Protection and Lawful Disclosure

40 Chapter 40: Clinical Professionalism and the GDC

40.1 The General Dental Council and Standards Principles 1 to 4 40.2 GDC Standards: Principles 5 to 9 40.3 The GDC Fitness to Practise Process 40.4 Clinical Governance and the Audit Cycle

41 Chapter 41: Health and Safety Law in Dental Practice

41.1 Health and Safety Legislation, COSHH, RIDDOR and Sharps

42 Chapter 42: Self-Management and Professional Development

42.1 Enhanced CPD, Lifelong Learning and Reflective Practice 42.2 Managing Time, Stress and Clinical Wellbeing 42.3 Leadership, Delegation and Practice Management

24.10 Re-Evaluation, Endpoints and Periodontal Surgery

Key Takeaways Explain This Topic AI

Re-evaluation must take place 8 to 12 weeks after step 2 instrumentation; assessing earlier records immature healing.

The endpoints of active therapy are a full-mouth plaque score below 20% and a full-mouth bleeding score below 10% to 15%, with no site of 4 mm or more bleeding on probing.

Residual pockets of 6 mm or more with bleeding in a compliant patient are the trigger for step 3 surgical or repeated non-surgical intervention.

Three-wall infrabony defects have the highest regenerative predictability and one-wall defects the lowest.

Enamel matrix derivative promotes formation of acellular extrinsic fibre cementum, while guided tissue regeneration relies on a barrier membrane to exclude epithelium.

Last updated: September 2026

  • 4. Step 3: Re-Evaluation and Endpoints of Therapy
  • Re-Evaluation Timing (8 to 12 Weeks)

Re-evaluation must occur 8 to 12 weeks post-Step 2 debridement . Evaluating earlier than 8 weeks records immature healing, as collagen remodelling and epithelial re-attachment require up to 3 months to achieve structural stability.

Clinical Endpoints of Active Periodontal Therapy

Under BSP guidelines, a patient has achieved successful endpoints of active therapy when:

Probing pocket depths are ≤ 4 mm \le 4\text{ mm} ≤ 4 mm without bleeding on probing (BOP).

Absence of deep pockets ≥ 6 mm \ge 6\text{ mm} ≥ 6 mm exhibiting bleeding.

Full-Mouth Plaque Score (FMPS) < 20 % < 20\% < 20% .

Full-Mouth Bleeding Score (FMBS) < 10 − 15 % < 10-15\% < 10 − 15% . Management Algorithm at 8–12 Week Re-Evaluation

│

├── Site displays PPD ≤ 4 mm with NO BOP?

│ └── YES ──> POCKET CLOSURE ACHIEVED. Transition patient to Step 4 (SPC).

│

├── Site displays PPD 4–5 mm WITH BOP?

│ └── YES ──> RESIDUAL INFLAMMATION. Repeat Step 2 subgingival instrumentation.

│

└── Site displays RESIDUAL DEEP POCKETS PPD ≥ 6 mm (especially with vertical defects)?

└── YES ──> Assess patient engagement (FMPS < 20%, FMBS < 30%).

├── Compliant & Motivated ─> Consider STEP 3 ADVANCED SURGICAL THERAPY

└── Poor Compliance/Plaque ──> Repeat non-surgical Step 1 and Step 2.

5. Surgical Periodontal Therapy: Resective vs Regenerative

Periodontal surgery (Step 3) is indicated exclusively when residual deep pockets ( ≥ 6 mm \ge 6\text{ mm} ≥ 6 mm ) persist following high-quality non-surgical therapy.

Important

Mandatory Prerequisites for Periodontal Surgery: Surgical intervention is strictly contraindicated in unmotivated patients with poor home care. Before any surgical flap is elevated, the patient must consistently demonstrate:

  • Full-Mouth Plaque Score (FMPS) < 20 % < 20\% < 20% ;
  • Full-Mouth Bleeding Score (FMBS) < 30 % < 30\% < 30% ;

Effective compliance with smoking cessation and systemic risk control.

Resective Periodontal Surgery

Resective procedures aim to surgically eliminate the soft tissue pocket wall or recontour osseous architecture to facilitate personal plaque maintenance:

Gingivectomy: Surgical excision of the diseased gingival pocket wall.

Indications: Suprabony pseudopockets, drug-induced gingival enlargement (DIGE), altered passive eruption.

Contraindications: Infrabony pockets extending apical to the alveolar crest; situations where pocket excision would remove all attached keratinized tissue, violating the mucogingival junction.

Apically Repositioned Flap (ARF) with Osseous Recontouring: A full-thickness flap elevated and sutured apically at the level of the recontoured alveolar crest. Osteoplasty (removal of non-supporting bone) and ostectomy (removal of supporting bone) eliminate osseous craters. Primarily restricted to posterior non-aesthetic zones due to severe subsequent root exposure.

Regenerative Periodontal Surgery

Regenerative surgery aims to recreate the lost periodontal attachment apparatus: new cementum, inserting periodontal ligament fibres, and alveolar bone. Infrabony Defect Morphologies (Goldman & Cohen)

  • 3-Wall Defect 2-Wall Defect 1-Wall Defect
  • (Three Osseous Walls Intact) (Two Osseous Walls Intact) (One Osseous Wall Remaining)
  • │ Tooth │ │ Tooth │ │ Tooth │
  • │ │ │ │ │ │
  • ┌─┴───────────────┴─┐ ┌─┴───────────────┴─┐ ┌─┴───────────────┴─┐
  • │ [Bone] ▲ [Bone]│ │ [Bone] ▲ │ │ ▲ │
  • │ [Bone] ◄ ● ►[Bone]│ │ [Bone] ◄ ● │ │ ● │
  • │ [Bone] ▼ [Bone]│ │ [Bone] ▼ │ │ ▼ │
  • └───────────────────┘ └───────────────────┘ └───────────────────┘
  • (Highest Predictability) (Moderate Predictability) (Poor Predictability)

Defect Type Intact Osseous Walls Biological Potential Clinical Recommendation

3-Wall Infrabony Defect Three bony walls surround defect (e.g., buccal, lingual, proximal) Highest regenerative predictability . Excellent blood clot containment, space maintenance, and proximity of osteogenic stem cells Ideal candidate for Enamel Matrix Derivative (EMD) and/or bone graft

2-Wall Infrabony Defect Two bony walls (e.g., interdental crater with buccal and lingual walls) Moderate regenerative predictability; clot stability requires structural support Candidate for combined GTR membrane and bone graft scaffold

1-Wall Infrabony Defect Only one bony wall intact (hemiseptal defect) Poorest regenerative predictability ; prone to soft tissue collapse and clot disruption Resective recontouring or conservative non-surgical maintenance

Regenerative Biomaterials and Biologics

Enamel Matrix Derivative (EMD / Emdogain): Purified hydrophobic porcine enamel matrix proteins (amelogenins) in a propylene glycol alginate carrier. Amelogenins mimic the biochemical cues of tooth development (Hertwig's epithelial root sheath), inducing mesenchymal stem cells on the root surface to differentiate into cementoblasts. Promotes true formation of acellular extrinsic fibre cementum , periodontal ligament, and alveolar bone.

Guided Tissue Regeneration (GTR): Placement of a mechanical barrier membrane (resorbable porcine collagen membrane or non-resorbable expanded polytetrafluoroethylene [ePTFE]) between the gingival flap and the root. The membrane physically prevents rapidly migrating gingival epithelial cells and gingival connective tissue fibroblasts from contacting the debrided root surface, permitting slower-growing pluripotent periodontal ligament and perivascular osteogenic cells to repopulate the root.

Bone Grafts and Scaffolds: Autografts (patient's own bone: osteogenic), Allografts (freeze-dried allogenic human bone: osteoinductive), Xenografts (deproteinized bovine bone mineral [DBBM / Bio-Oss]: osteoconductive matrix), and Alloplasts (synthetic beta-tricalcium phosphate). They provide mechanical space maintenance preventing flap collapse.

Choosing Between Resective and Regenerative Surgery

The decision is driven by the morphology of the defect, and this is what SBAs test. Regeneration — with guided tissue regeneration membranes, enamel matrix derivative, or bone grafts — is predictable in narrow, deep, contained intrabony defects with two or three remaining bony walls and in Class II mandibular furcations , where the surrounding walls provide space maintenance and a source of progenitor cells. Resective surgery — apically repositioned flaps, osseous recontouring, root resection, tunnelling — suits shallow, wide, one-walled defects and horizontal bone loss , where regeneration is unpredictable, and is used to achieve a maintainable architecture.

The prerequisites for any periodontal surgery are examinable and absolute: excellent plaque control demonstrated over time, smoking cessation or at least a frank discussion of its effect on outcomes, control of diabetes, and completion of non-surgical therapy with adequate healing time. Operating on a patient with poor plaque control produces worse results than not operating, and recommending surgery in that situation is a wrong answer.

Crown Lengthening and Restorative Interfaces

Where a restorative margin would encroach on the supracrestal attachment, surgical crown lengthening or orthodontic extrusion restores the biological dimension. The accepted requirement is at least 2 mm of supracrestal attachment plus an adequate sulcus, so approximately 3 mm of sound tooth structure coronal to the bone crest is created, and the tissues are allowed to mature — conventionally three months, longer in the aesthetic zone — before definitive impressions.